Xeticam (Levetiracetam) Tablet is indicated as:

Monotherapy:
• In the treatment of partial onset seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Adjunctive Therapy:
• In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children 6 years of age or above with epilepsy.
• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
• In the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 6 years of age with Idiopathic Generalized Epilepsy